FemTech Startups Currently Hiring

Femtech is hiring. That is the article. The sector grew from a niche conversation into a $46.47 billion global market in 2025, expanding at a 20.2% compound annual growth rate, and the companies inside it are actively posting roles right now. This piece maps those companies and those roles so job seekers can act on the signal, not just absorb the statistic.

One methodological note before we begin: market size estimates in femtech vary considerably depending on how analysts define the sector's boundaries. Research and Markets puts 2025 global value at $46.47 billion; Fortune Business Insights arrives at $9.12 billion for the same year. The precise figure is less important than the directional consensus, which is unambiguous. A sector that has minted 13 unicorns, logged 67 tracked acquisitions worth $3.8 billion in disclosed value since 2010, and attracted GV and General Catalyst as repeat institutional backers is not a speculative thesis. It is a built industry with proven exits and active hiring budgets.

How Recent Funding Rounds Translate Into Open Headcount

The first question any serious job seeker should ask is not "is this sector growing?" but "which specific companies have money to hire right now?" Those are different questions, and conflating them wastes time.

In 2025, femtech companies raised $724 million. The first half of 2026 came in at $239 million, which puts the full-year pace at roughly $478 million, a decline of about 34% year-over-year. That sounds alarming until you look at how the capital is distributed. Across the mid-2025 to mid-2026 window, the top ten deals captured 91.37% of total funding, with a median round of $6.0 million and an average of $17.9 million. The story is not collapse; it is consolidation around a relatively short list of well-capitalized companies. That is actually useful information for a job seeker, because it tells you where to concentrate your attention.

The pattern is reliable enough to use as a filter: companies that closed funding rounds in the past six to twelve months have budget to hire. Companies that haven't are probably not your immediate opportunity. GV was the most active femtech investor from 2022 through 2025, participating in eight deals totaling over $350 million. General Catalyst invested over $200 million in Maven Clinic alone. Institutional conviction at that scale funds multi-year hiring plans, not one-quarter sprints.

It is also worth considering where the capital is concentrated by subcategory. Fertility and IVF captured 44% of all femtech funding in 2025, making reproductive health the single deepest hiring pool in the sector. Menopause-focused companies reached $104 million in venture investment in 2025, up 9% over three years per Dealroom, and that category has crossed the threshold from "emerging" to "mainstream institutional allocation." The projected runway to $118.99 billion by 2030 at a 20.8% CAGR is what is driving hiring now, not current revenue alone. Investors are building ahead of demand, and that build-out requires headcount.

The Femtech Companies Actually Posting Roles Right Now

Knowing the sector is healthy is table stakes. The useful question is which specific companies are actively hiring today.

Maven Clinic is the largest virtual clinic for women's and family health, working with employers and health plans to improve maternal outcomes and reduce costs. It is one of the best-capitalized employers in the sector, backed by over $200 million from General Catalyst. Corporate and provider roles post regularly at mavenclinic.com/careers. If you want scale, stability, and institutional backing in one company, Maven is the obvious anchor.

Midi Health is the menopause category leader, a virtual care platform for midlife women's health backed by GV and Emerson Collective. The company proved that insurance-covered virtual menopause care can scale, which is a harder achievement than it sounds. As of August 2026, Glassdoor listed 23 open positions, spanning clinical and non-clinical tracks.

Teal Health sits in women's cancer diagnostics and ranks among Seedtable's 2026 leaders. Emerson Collective led a significant round focused on underserved women's health needs. Roles appear on Built In and Glassdoor; the company's focus on diagnostics means regulatory and clinical backgrounds are particularly valued here.

Carrot Fertility is the global fertility benefits platform for employers, covering egg freezing, IVF, adoption, donor, and gestational services across geographies and family structures. Because it sells to employers rather than directly to patients, it regularly posts senior clinical solutions manager and enterprise account manager roles. The commercial and customer success functions here are as prominent as the clinical ones. Candidates from health plan or employer benefits backgrounds should pay close attention.

Mae Health is a venture-backed digital platform for maternal and infant wellbeing built around a community-led model with continuous engagement and risk assessment. It is actively hiring member services, advanced practice provider, and outreach specialist roles. For candidates coming from community health or maternal care backgrounds, Mae is a natural entry point.

Diana Health operates a network of women's health practices partnering with hospitals for both in-person and digital care. Founded in 2020 and expanding its clinic footprint following its most recent funding round, Diana hires across clinical, operational, and digital delivery tracks simultaneously.

BrightHeart, based in Paris and founded in 2020, raised an €11 million Series A in January 2026. Its product uses AI-driven ultrasound screening to detect congenital heart defects in fetuses, providing real-time guidance to clinicians. A fresh Series A typically means an active hiring phase. European base suits candidates open to Paris or remote EU roles.

BeSounds Breast, founded in San Francisco in 2023, raised $9.15 million including a $6.8 million seed in September 2025. Its breast imaging technology requires no radiation, compression, or contrast dye, and clinical data shows AI detection finding more cancers than mammography alone. At this stage, roles will skew generalist with high ownership per hire.

Evela, based in Berlin and founded in 2020, raised €2.6 million including a €2 million pre-seed in September 2025. It is building menopausal care as a mainstream workplace benefit through a B2B2C model targeting employers. At pre-seed scale, roles are first-hire territory: high autonomy, broad scope, and real risk.

Visby Medical offers at-home STI testing for women with recent FDA approval. Post-approval commercialization cycles reliably trigger waves of sales, marketing, and operations hiring. If you have a medical device or diagnostics commercial background, this is worth watching closely.

Inne, a European startup with roughly €16 million raised, is building a saliva-based hormone biosensor for real-time fertility tracking. The hardware-plus-software architecture means the company needs engineering and regulatory specialists alongside UX designers and clinical positions. That breadth of role type is unusual at this funding level.

Wellfound maintains a curated collection of femtech startups actively hiring and is worth bookmarking as a supplemental discovery tool.

What Roles These Companies Are Actually Hiring For

Three broad functional tracks dominate current femtech hiring, and they are not equally weighted across all company types.

Clinical and regulatory roles command the most attention at diagnostic and device companies. Advanced practice providers, clinical research associates, and regulatory affairs specialists are in active demand at BrightHeart, BeSounds, and Visby Medical, particularly as the EU AI Act's full implementation in August 2026 has raised the compliance bar for European companies operating AI-assisted diagnostics. European femtech roles increasingly require clinical, regulatory, or medical device backgrounds as a baseline, not a differentiator.

Product and engineering roles are heaviest at platform companies and hardware-software hybrids. Maven, Midi, and Carrot all hire product managers, UX researchers, and software engineers at senior levels. Inne adds AI/ML specialization to the mix, given the biosensor's real-time data processing requirements. Per Femtech Search, Clinical Operations Managers and Product Leads rank among the most consistently demanded roles across the sector right now.

Commercial and growth roles are the underappreciated hiring category in femtech, and they are where adjacent-industry candidates have the clearest entry path. B2B benefit platforms like Carrot and Evela sell to HR and benefits buyers, so enterprise account managers, customer success managers, outreach specialists, and partnerships leads are as important to these businesses as any clinical hire. Candidates with employer benefits, health plan, or B2B SaaS sales experience have a direct translation that does not require clinical credentials.

One more thing worth noting: fractional and project-based roles are a legitimate and growing entry point, not a consolation prize. Femtech Search runs a dedicated talent network in the UK and EU specifically for fractional senior positions. If you are transitioning into the sector, a fractional engagement at a funded company is a more efficient credentialing strategy than many people realize.

Where to Find Femtech Job Listings Beyond Company Career Pages

The sector is big enough to have developed its own infrastructure for job discovery, but fragmented enough that a single source is never sufficient.

The most focused aggregator is Femtech Insider's job board at jobs.femtechinsider.com, updated regularly with roles across company stages and geographies. Femtech Search (femtechsearch.com/talent-network) covers the UK and EU, with a particular depth in fractional and senior project-based positions.

On general platforms, Wellfound maintains a curated femtech startup hiring collection that is worth checking directly rather than relying on keyword search. Built In lists open roles at companies including Teal Health and is particularly useful for tech-track positions at U.S.-based startups. For Glassdoor and Indeed, a critical tactical note: set up job alerts by company name rather than the keyword "femtech." The tag is inconsistently applied across postings, so keyword searches miss a significant portion of active listings.

For roles that do not surface on the major boards, In Women's Health newsletter runs a recurring #HiringWednesday series. It is a low-friction signal that catches legitimate opportunities early.

Geography matters more in this sector than people expect. The United States has the largest company concentration, with over 1,200 companies tracked by Tracxn as of April 2026, and San Francisco dominates early-stage roles specifically. London and New York are the next major hubs. For European roles, Seedtable's 2026 ranking tracks 46 funded femtech startups collectively worth roughly $2.5 billion in raised capital and is a reliable shortlist of companies with actual hiring budgets.

What to Expect From a Femtech Job Search in the Current Market

The 2021 to 2022 hiring environment in digital health broadly, and femtech specifically, was anomalous. Capital was cheap, companies were scaling aggressively, and the bar for fit was lower than it should have been. That environment is not coming back. The current market is tighter, more selective, and more honest about it.

That is not a reason to avoid the sector. It is a reason to be precise.

Consolidation means the companies with deep headcount budgets are a short list. Maven, Midi, Teal, and Carrot sit at the top of it. Targeting your search toward recently funded companies and ignoring everything else is a reasonable heuristic that saves weeks. The top ten deals capturing over 91% of total funding in the mid-2025 to mid-2026 window tells you exactly where the hiring budget actually lives.

But what if your background is digital health or employer benefits rather than femtech specifically? That raises a question worth sitting with: is femtech-specific experience actually required, or does the sector recruit based on functional competency? The answer, at least for product and commercial roles, is the latter. Maven and Carrot regularly pull candidates from adjacent digital health, telehealth, and employer benefits software backgrounds. The product and commercial stacks are similar enough that a targeted cover narrative bridges the gap. The clinical tracks are more credentialed and less permeable, but even there, companies like Mae Health actively recruit from community health backgrounds that do not originate in femtech.

The subcategories most likely to generate hiring momentum over the next 12 to 18 months are menopause (now mainstream for institutional investors and scaling rapidly), AI-powered diagnostics (BrightHeart and BeSounds are in active post-funding build phases), and maternal health (Mae and Diana Health are both expanding access models). These are not long-term predictions; they are observable from current funding activity.

The honest summary: femtech is not the frothy market it was, and it is not a sector in distress. It is a maturing industry selecting for quality of fit over speed of hire. Which is, if you are actually good at what you do, a better environment to enter than the alternative.